(Q34001144)

30 July 2017

1 reference

title

HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies (English)

1 reference

30 July 2017

1 reference

1 reference

Gary R Matyas

4

0 references

Mangala Rao

series ordinal

5

object named as

Mangala Rao

1 reference

30 July 2017

Carl R Alving

1

1 reference

30 July 2017

Zoltan Beck

series ordinal

2

1 reference

30 July 2017

Nicos Karasavva

series ordinal

3

1 reference

30 July 2017

publication date

1 November 2006

1 reference

Molecular Membrane Biology

30 July 2017

published in

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

453-465

1 reference

Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Thermodynamics of membrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Lipid composition and fluidity of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Antibodies to lipids and liposomes: immunology and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Antibodies to liposomal phosphatidylserine and phosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Ceramide-enriched membrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

The HIV lipidome: a raft with an unusual composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

HIV vaccine design and the neutralizing antibody problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Phosphatidylserine on HIV Envelope Is a Cofactor for Infection of Monocytic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Modulation of HIV-like particle assembly in vitro by inositol phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

The structural biology of type I viral membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Probing phosphoinositide functions in signaling and membrane trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Antibodies against heat shock proteins and cholesterol in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Anti-cholesterol antibodies in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Structure of a V3-containing HIV-1 gp120 core

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Pathogens: raft hijackers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Mitogenesis in response to PDGF and bombesin abolished by microinjection of antibody to PIP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Progress towards the development of a HIV-1 gp41-directed vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

21 January 2018

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Dangerous liaisons at the virological synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Lipid rafts: bringing order to chaos

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Lipid rafts and membrane dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

The differential miscibility of lipids as the basis for the formation of functional membrane rafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Functional rafts in cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Model systems, lipid rafts, and cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

The fluid mosaic model of the structure of cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Cross-reactions of nucleic acids with monoclonal antibodies to phosphatidylinositol phosphate and cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Dynamics of raft molecules in the cell and artificial membranes: approaches by pulse EPR spin labeling and single molecule optical microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Antibodies to cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Antibodies to liposomal phosphatidylcholine and phosphatidylsulfocholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Phosphatidylinositol 4-phosphate synthesis in immunoisolated caveolae-like vesicles and low buoyant density non-caveolar membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

Cholesterol sulphate-reactive autoantibodies are specifically increased in chronic chagasic human patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09687860600935348

10.1080/09687860600935348

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference